Considerations for whole exome sequencing unique to prenatal care
Whole exome sequencing (WES) is increasingly being used in the prenatal setting. The emerging data support the clinical utility of prenatal WES based on its diagnostic yield, which can be as high as 80% for certain ultrasound findings. However, detailed practice and laboratory guidelines, addressing the indications for prenatal WES and the surrounding technical, interpretation, ethical, and counseling issues, are still lacking. Herein, we review the literature and summarize the most recent findings and applications of prenatal WES. This review offers specialists and clinical genetic laboratorians a body of evidence and expert opinions that can serve as a resource to assist in their practice. Finally, we highlight the emerging technologies that promise a future of prenatal WES without the risks associated with invasive testing.
We would like to acknowledge Matt Lebo, PhD and Kalotina Machini, PhD, CGC for critical review of the manuscript.
Compliance with ethical standards
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
- Amr SS et al (2018) Allele-specific droplet digital PCR combined with a next-generation sequencing-based algorithm for diagnostic copy number analysis in genes with high homology: proof of concept using Stereocilin. Clin Chem 64:705–714. https://doi.org/10.1373/clinchem.2017.280685 CrossRefPubMedGoogle Scholar
- Baylor Genetics (2018) Performance of the newly developed non-invasive prenatal multi-gene sequencing screen. White Paper. https://www.baylorgenetics.com/preseek/. Accessed 1 June 2018
- Bischoff FZ, Simpson JL (2006) Endocervical fetal trophoblast for prenatal genetic diagnosis. Curr Opin Obstet Gynecol 18:216–220. https://doi.org/10.1097/01.gco.0000192985.22718.17 CrossRefPubMedGoogle Scholar
- Chitty LS, Mason S, Barrett AN, McKay F, Lench N, Daley R, Jenkins LA (2015) Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn 35:656–662. https://doi.org/10.1002/pd.4583 CrossRefPubMedPubMedCentralGoogle Scholar
- International Society for Prenatal Diagnosis, Society for M, Fetal M, Perinatal Quality F (2018) Joint Position Statement from the International Society for Prenatal Diagnosis (ISPD), the Society for Maternal Fetal Medicine (SMFM), and the Perinatal Quality Foundation (PQF) on the use of genome-wide sequencing for fetal diagnosis. Prenat Diagn 38:6–9. https://doi.org/10.1002/pd.5195 CrossRefGoogle Scholar
- Kalia SS et al (2017) Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med 19:249–255. https://doi.org/10.1038/gim.2016.190 CrossRefPubMedGoogle Scholar
- Kobayashi Y, Yang S, Nykamp K, Garcia J, Lincoln SE, Topper SE (2017) Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation. Genome Med 9:13. https://doi.org/10.1186/s13073-017-0403-7 CrossRefPubMedPubMedCentralGoogle Scholar
- Moser G, Drewlo S, Huppertz B, Armant DR (2018) Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies. Hum Reprod Update. https://doi.org/10.1093/humupd/dmy008 CrossRefPubMedPubMedCentralGoogle Scholar
- Nagan N, Faulkner NE, Curtis C, Schrijver I (2011) Laboratory guidelines for detection, interpretation, and reporting of maternal cell contamination in prenatal analyses a report of the association for molecular pathology. J Mol Diagn 13:7–11. https://doi.org/10.1016/j.jmoldx.2010.11.013 CrossRefPubMedPubMedCentralGoogle Scholar
- Pangalos C, Hagnefelt B, Lilakos K, Konialis C (2016) First applications of a targeted exome sequencing approach in fetuses with ultrasound abnormalities reveals an important fraction of cases with associated gene defects. PeerJ 4:e1955. https://doi.org/10.7717/peerj.1955 CrossRefPubMedPubMedCentralGoogle Scholar
- Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30 CrossRefPubMedPubMedCentralGoogle Scholar
- Steinberg S, Katsanis S, Moser A, Cutting G (2005) Biochemical analysis of cultured chorionic villi for the prenatal diagnosis of peroxisomal disorders: biochemical thresholds and molecular sensitivity for maternal cell contamination detection. J Med Genet 42:38–44. https://doi.org/10.1136/jmg.2004.023556 CrossRefPubMedPubMedCentralGoogle Scholar